Evaluation of 64Cu radiolabeled anti-hPD-L1 Nb6 for positron emission tomography imaging in lung cancer tumor mice model

Naturally occurring antibodies devoid of light chains

C. Hamers‐Casterman, T. Atarhouch, Serge Muyldermans et al. · Nature · 1993 · 3.2K citations

Immunocytochemical Technique, Medicine, Immunology +5

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

Frederike Bensch, Elly L. van der Veen, Marjolijn N. Lub–de Hooge et al. · Nature Medicine · 2018 · 702 citations · Full text

Oncologic Imaging, Pd-l1 Blockade, Medicine +11

Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies

Marius Ilié, Élodie Long-Mira, Coraline Bence et al. · Annals of Oncology · 2015 · 566 citations

Translational Medicine, Clinical Translation, Medicine +7

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

Anna-Larissa N. Niemeijer, David Leung, Marc C. Huisman et al. · Nature Communications · 2018 · 460 citations · Full text

Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook

Mehdi Arbabi‐Ghahroudi · Frontiers in Immunology · 2017 · 205 citations · Full text